ORLANDO, Fla.—The leader of Gilead Sciences' Kite Pharma is sure that anito-cel, the biotech’s next-generation multiple myeloma CAR-T challenger to Carvykti, is ready for prime time—and that the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an effective cure for beta-thalassemia and sickle cell disease in children younger ...

JAMES CITY COUNTY, Va. — CEL Critical Power, a global provider of power solutions, will invest $5.2 million to open its first American manufacturing facility in James City County, Governor Glenn ...

Still, a fix is a fix. Mostly. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on Google Well, it's my own fault, ...

More than a third of patients with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with the CAR T-cell therapy obecabtagene autoleucel (obe-cel) remained in remission at a ...

CEL-SCI Corporation (NYSE:CVM) shares tumbled 38.19% in after-hours trading to $8.06 on Tuesday following the cancer immunotherapy company’s announcement of a $10 million public offering priced below ...

Researchers from Trina Solar and China’s Nanchang University claim to have verified that back-contact solar modules outperform TOPCon modules only when fewer than three cells in a substring are shaded ...

VIENNA, Va.--(BUSINESS WIRE)-- CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the closing of its underwritten ...

The masked anti-Israel rabble-rousers who stormed Columbia University’s library passed out flyers lionizing alleged Palestinian terrorist Bassel al-Araj as a “militant intellectual,” The Post has ...

In part 4 of an interview with The American Journal of Managed Care®, Frederick L. Locke, MD, provides insight on the design of the ALPHA and ALPHA2 trials, which are investigating the chimeric ...

To help get you primed and ready for another week in mobile gaming, we’ve curated the biggest stories you need to know from the last seven days. 1) Update: Unity lays off staff and axes Behavior team ...